Skip to main content
Top
Published in: Clinical Rheumatology 8/2012

01-08-2012 | Original Article

Predictors of health-related quality of life and fatigue in systemic sclerosis: evaluation of the EuroQol-5D and FACIT-F assessment tools

Authors: Gemma Strickland, John Pauling, Charlotte Cavill, Neil McHugh

Published in: Clinical Rheumatology | Issue 8/2012

Login to get access

Abstract

This study evaluates predictors of health-related quality of life (HRQoL) and fatigue in systemic sclerosis (SSc) using two novel self-report indices. A cross-sectional study of patients with SSc was undertaken using a postal questionnaire including the EuroQol-5Domain health questionnaire (EQ-5D™), Functional Assessment of Chronic Illness Therapy—Fatigue scale (FACIT-F) and the Scleroderma Health Assessment Questionnaire (SHAQ). The EQ-5D assesses five domains of health quality and is quantified as a time trade-off (TTO) value and patient global assessment (0–100 visual analogue scale [VAS]). The FACIT-F is a 13-item questionnaire (0–52 scale). Higher scores for both the EQ-5D and FACIT-F indicate better health. Case notes were scrutinised for patient demographics, disease duration, serology and clinical phenotype. Sixty-eight patients (60 females, mean age 62.6 years) completed the questionnaires. Fatigue correlated closely with HRQoL (r s = 0.78 and 0.77 for FACIT-F vs. EQ-5D VAS and TTO respectively, p < 0.01) and disability (r s = −0.74 for FACIT-F vs. HAQ-DI, p < 0.01). Pain was the most frequently reported health problem (80 %) in the EQ-5D. HRQoL also correlated closely with disability (r s = 0.83 for EQ-5D vs. HAQ-DI, p < 0.01). SHAQ-VAS scores correlated well with the FACIT-F, EQ-5D and HAQ-DI scores (p < 0.05 for all comparisons). Of the patient demographics and clinical disease associations, only the absence of upper gastrointestinal complications was associated with better levels of fatigue, HRQoL and function. There is a strong correlation between disability, fatigue and HRQoL measured using self-reports, possibly reflecting similarly perceived health beliefs amongst patients across outcomes. There was little association between self-report indices and patient demographics and/or clinical phenotype.
Appendix
Available only for authorised users
Literature
1.
go back to reference Merkel PA, Clements PJ, Reveille JD, Suarez-Almazor ME, Valentini G, Furst DE (2003) Current status of outcome measure development for clinical trials in systemic sclerosis. Report from OMERACT 6. J Rheumatol 30(7):1630–1647PubMed Merkel PA, Clements PJ, Reveille JD, Suarez-Almazor ME, Valentini G, Furst DE (2003) Current status of outcome measure development for clinical trials in systemic sclerosis. Report from OMERACT 6. J Rheumatol 30(7):1630–1647PubMed
2.
go back to reference Thombs BD, Hudson M, Bassel M, Taillefer SS, Baron M (2009) Sociodemographic, disease, and symptom correlates of fatigue in systemic sclerosis: evidence from a sample of 659 Canadian Scleroderma Research Group Registry patients. Arthritis Rheum 61(7):966–973, Jul 15PubMedCrossRef Thombs BD, Hudson M, Bassel M, Taillefer SS, Baron M (2009) Sociodemographic, disease, and symptom correlates of fatigue in systemic sclerosis: evidence from a sample of 659 Canadian Scleroderma Research Group Registry patients. Arthritis Rheum 61(7):966–973, Jul 15PubMedCrossRef
3.
go back to reference Thombs BD, Bassel M, McGuire L, Smith MT, Hudson M, Haythornthwaite JA (2008) A systematic comparison of fatigue levels in systemic sclerosis with general population, cancer and rheumatic disease samples. Rheumatology (Oxford) 47(10):1559–1563CrossRef Thombs BD, Bassel M, McGuire L, Smith MT, Hudson M, Haythornthwaite JA (2008) A systematic comparison of fatigue levels in systemic sclerosis with general population, cancer and rheumatic disease samples. Rheumatology (Oxford) 47(10):1559–1563CrossRef
4.
go back to reference Bassel M, Hudson M, Taillefer SS, Schieir O, Baron M, Thombs BD (2011) Frequency and impact of symptoms experienced by patients with systemic sclerosis: results from a Canadian National Survey. Rheumatology (Oxford) 50(4):762–767CrossRef Bassel M, Hudson M, Taillefer SS, Schieir O, Baron M, Thombs BD (2011) Frequency and impact of symptoms experienced by patients with systemic sclerosis: results from a Canadian National Survey. Rheumatology (Oxford) 50(4):762–767CrossRef
5.
go back to reference Cella D, Yount S, Sorensen M, Chartash E, Sengupta N, Grober J (2005) Validation of the Functional Assessment of Chronic Illness Therapy Fatigue Scale relative to other instrumentation in patients with rheumatoid arthritis. J Rheumatol 32(5):811–819PubMed Cella D, Yount S, Sorensen M, Chartash E, Sengupta N, Grober J (2005) Validation of the Functional Assessment of Chronic Illness Therapy Fatigue Scale relative to other instrumentation in patients with rheumatoid arthritis. J Rheumatol 32(5):811–819PubMed
6.
go back to reference Frech T, Hays RD, Maranian P, Clements PJ, Furst DE, Khanna D (2011) Prevalence and correlates of sleep disturbance in systemic sclerosis—results from the UCLA scleroderma quality of life study. Rheumatology (Oxford) 50(7):1280–1287CrossRef Frech T, Hays RD, Maranian P, Clements PJ, Furst DE, Khanna D (2011) Prevalence and correlates of sleep disturbance in systemic sclerosis—results from the UCLA scleroderma quality of life study. Rheumatology (Oxford) 50(7):1280–1287CrossRef
7.
go back to reference Hudson M, Thombs BD, Steele R, Panopalis P, Newton E, Baron M (2009) Health-related quality of life in systemic sclerosis: a systematic review. Arthritis Rheum 61(8):1112–1120, Aug 15PubMedCrossRef Hudson M, Thombs BD, Steele R, Panopalis P, Newton E, Baron M (2009) Health-related quality of life in systemic sclerosis: a systematic review. Arthritis Rheum 61(8):1112–1120, Aug 15PubMedCrossRef
8.
go back to reference Group E (1990) Euroqol—a new facility for the measurement of health-related quality of life. Health Policy 16:199–208CrossRef Group E (1990) Euroqol—a new facility for the measurement of health-related quality of life. Health Policy 16:199–208CrossRef
9.
go back to reference Gualtierotti R, Scalone L, Ingegnoli F, Cortesi P, Lubatti C, Zeni S et al (2010) Health related quality of life assessment in patients with systemic sclerosis. Reumatismo 62(3):210–214, Jul-SepPubMed Gualtierotti R, Scalone L, Ingegnoli F, Cortesi P, Lubatti C, Zeni S et al (2010) Health related quality of life assessment in patients with systemic sclerosis. Reumatismo 62(3):210–214, Jul-SepPubMed
10.
go back to reference Muller H, Rehberger P, Gunther C, Schmitt J. Determinants of disability, quality of life and depression in dermatological patients with systemic scleroderma. Br J Dermatol. 2011 Sep 14 Muller H, Rehberger P, Gunther C, Schmitt J. Determinants of disability, quality of life and depression in dermatological patients with systemic scleroderma. Br J Dermatol. 2011 Sep 14
11.
go back to reference LeRoy EC, Medsger TA Jr (2001) Criteria for the classification of early systemic sclerosis. J Rheumatol 28(7):1573–1576PubMed LeRoy EC, Medsger TA Jr (2001) Criteria for the classification of early systemic sclerosis. J Rheumatol 28(7):1573–1576PubMed
12.
go back to reference Clements PJ, Lachenbruch PA, Seibold JR, Zee B, Steen VD, Brennan P et al (1993) Skin thickness score in systemic sclerosis: an assessment of interobserver variability in 3 independent studies. J Rheumatol 20(11):1892–1896PubMed Clements PJ, Lachenbruch PA, Seibold JR, Zee B, Steen VD, Brennan P et al (1993) Skin thickness score in systemic sclerosis: an assessment of interobserver variability in 3 independent studies. J Rheumatol 20(11):1892–1896PubMed
13.
go back to reference Badesch DB, Champion HC, Sanchez MA, Hoeper MM, Loyd JE, Manes A et al (2009) Diagnosis and assessment of pulmonary arterial hypertension. J Am Coll Cardiol 54(1 Suppl):S55–S66, Jun 30PubMedCrossRef Badesch DB, Champion HC, Sanchez MA, Hoeper MM, Loyd JE, Manes A et al (2009) Diagnosis and assessment of pulmonary arterial hypertension. J Am Coll Cardiol 54(1 Suppl):S55–S66, Jun 30PubMedCrossRef
14.
go back to reference Steen VD, Medsger TA Jr (1997) The value of the Health Assessment Questionnaire and special patient-generated scales to demonstrate change in systemic sclerosis patients over time. Arthritis Rheum 40(11):1984–1991PubMedCrossRef Steen VD, Medsger TA Jr (1997) The value of the Health Assessment Questionnaire and special patient-generated scales to demonstrate change in systemic sclerosis patients over time. Arthritis Rheum 40(11):1984–1991PubMedCrossRef
15.
go back to reference Bruce B, Fries JF (2003) The Stanford Health Assessment Questionnaire: a review of its history, issues, progress, and documentation. J Rheumatol 30(1):167–178PubMed Bruce B, Fries JF (2003) The Stanford Health Assessment Questionnaire: a review of its history, issues, progress, and documentation. J Rheumatol 30(1):167–178PubMed
16.
go back to reference Marra CA, Esdaile JM, Guh D, Kopec JA, Brazier JE, Koehler BE et al (2004) A comparison of four indirect methods of assessing utility values in rheumatoid arthritis. Med Care 42(11):1125–1131PubMedCrossRef Marra CA, Esdaile JM, Guh D, Kopec JA, Brazier JE, Koehler BE et al (2004) A comparison of four indirect methods of assessing utility values in rheumatoid arthritis. Med Care 42(11):1125–1131PubMedCrossRef
17.
go back to reference Yellen SB, Cella DF, Webster K, Blendowski C, Kaplan E (1997) Measuring fatigue and other anemia-related symptoms with the Functional Assessment of Cancer Therapy (FACT) measurement system. J Pain Symptom Manag 13:63–74CrossRef Yellen SB, Cella DF, Webster K, Blendowski C, Kaplan E (1997) Measuring fatigue and other anemia-related symptoms with the Functional Assessment of Cancer Therapy (FACT) measurement system. J Pain Symptom Manag 13:63–74CrossRef
18.
go back to reference Cohen J. Applied multiple regression/correlation analysis for the behavioural sciences. 2nd ed. Hillsdale N, editor: Erlbaum; 2003 Cohen J. Applied multiple regression/correlation analysis for the behavioural sciences. 2nd ed. Hillsdale N, editor: Erlbaum; 2003
19.
go back to reference Poole JL, Williams CA, Bloch DA, Hollak B, Spitz P (1995) Concurrent validity of the Health Assessment Questionnaire Disability Index in Scleroderma. Arthritis Care Res 8(3):189–193PubMedCrossRef Poole JL, Williams CA, Bloch DA, Hollak B, Spitz P (1995) Concurrent validity of the Health Assessment Questionnaire Disability Index in Scleroderma. Arthritis Care Res 8(3):189–193PubMedCrossRef
20.
go back to reference Clements PJ, Wong WK, Hurwitz EL, Furst DE, Mayes M, White B et al (2001) The Disability Index of the Health Assessment Questionnaire is a predictor and correlate of outcome in the high-dose versus low-dose penicillamine in systemic sclerosis trial. Arthritis Rheum 44(3):653–661PubMedCrossRef Clements PJ, Wong WK, Hurwitz EL, Furst DE, Mayes M, White B et al (2001) The Disability Index of the Health Assessment Questionnaire is a predictor and correlate of outcome in the high-dose versus low-dose penicillamine in systemic sclerosis trial. Arthritis Rheum 44(3):653–661PubMedCrossRef
21.
go back to reference Webster K, Cella D, Yost K (2003) The Functional Assessment of Chronic Illness Therapy (FACIT) Measurement System: properties, applications, and interpretation. Health Qual Life Outcomes 1:79PubMedCrossRef Webster K, Cella D, Yost K (2003) The Functional Assessment of Chronic Illness Therapy (FACIT) Measurement System: properties, applications, and interpretation. Health Qual Life Outcomes 1:79PubMedCrossRef
22.
go back to reference Lai JS, Beaumont JL, Ogale S, Brunetta P, Cella D (2011) Validation of the functional assessment of chronic illness therapy-fatigue scale in patients with moderately to severely active systemic lupus erythematosus, participating in a clinical trial. J Rheumatol 38(4):672–679PubMedCrossRef Lai JS, Beaumont JL, Ogale S, Brunetta P, Cella D (2011) Validation of the functional assessment of chronic illness therapy-fatigue scale in patients with moderately to severely active systemic lupus erythematosus, participating in a clinical trial. J Rheumatol 38(4):672–679PubMedCrossRef
23.
go back to reference Stratton R, Wilson H, Black C (2001) Pilot study of anti-thymocyte globulin plus mycophenolate mofetil in recent-onset diffuse scleroderma. Rheumatology 40:84–88PubMedCrossRef Stratton R, Wilson H, Black C (2001) Pilot study of anti-thymocyte globulin plus mycophenolate mofetil in recent-onset diffuse scleroderma. Rheumatology 40:84–88PubMedCrossRef
24.
go back to reference Rannou F, Poiraudeau S, Berezne A, Baubet T, Le-Guern V, Cabane J et al (2007) Assessing disability and quality of life in systemic sclerosis: construct validities of the Cochin Hand Function Scale, Health Assessment Questionnaire (HAQ), Systemic Sclerosis HAQ, and Medical Outcomes Study 36-Item Short Form Health Survey. Arthritis Rheum 57(1):94–102, Feb 15PubMedCrossRef Rannou F, Poiraudeau S, Berezne A, Baubet T, Le-Guern V, Cabane J et al (2007) Assessing disability and quality of life in systemic sclerosis: construct validities of the Cochin Hand Function Scale, Health Assessment Questionnaire (HAQ), Systemic Sclerosis HAQ, and Medical Outcomes Study 36-Item Short Form Health Survey. Arthritis Rheum 57(1):94–102, Feb 15PubMedCrossRef
25.
go back to reference van Hoogmoed D, Fransen J, Bleijenberg G, van Riel P (2010) Physical and psychosocial correlates of severe fatigue in rheumatoid arthritis. Rheumatology (Oxford) 49(7):1294–1302CrossRef van Hoogmoed D, Fransen J, Bleijenberg G, van Riel P (2010) Physical and psychosocial correlates of severe fatigue in rheumatoid arthritis. Rheumatology (Oxford) 49(7):1294–1302CrossRef
26.
go back to reference Del Rosso A, Boldrini M, D'Agostino D, Placidi GP, Scarpato A, Pignone A et al (2004) Health-related quality of life in systemic sclerosis as measured by the Short Form 36: relationship with clinical and biologic markers. Arthritis Rheum 51(3):475–481, Jun 15PubMedCrossRef Del Rosso A, Boldrini M, D'Agostino D, Placidi GP, Scarpato A, Pignone A et al (2004) Health-related quality of life in systemic sclerosis as measured by the Short Form 36: relationship with clinical and biologic markers. Arthritis Rheum 51(3):475–481, Jun 15PubMedCrossRef
27.
go back to reference Nguyen C, Berezne A, Baubet T, Mestre-Stanislas C, Rannou F, Papelard A et al (2011) Association of gender with clinical expression, quality of life, disability, and depression and anxiety in patients with systemic sclerosis. PLoS One 6(3):e17551PubMedCrossRef Nguyen C, Berezne A, Baubet T, Mestre-Stanislas C, Rannou F, Papelard A et al (2011) Association of gender with clinical expression, quality of life, disability, and depression and anxiety in patients with systemic sclerosis. PLoS One 6(3):e17551PubMedCrossRef
Metadata
Title
Predictors of health-related quality of life and fatigue in systemic sclerosis: evaluation of the EuroQol-5D and FACIT-F assessment tools
Authors
Gemma Strickland
John Pauling
Charlotte Cavill
Neil McHugh
Publication date
01-08-2012
Publisher
Springer-Verlag
Published in
Clinical Rheumatology / Issue 8/2012
Print ISSN: 0770-3198
Electronic ISSN: 1434-9949
DOI
https://doi.org/10.1007/s10067-012-1997-1

Other articles of this Issue 8/2012

Clinical Rheumatology 8/2012 Go to the issue
Live Webinar | 27-06-2024 | 18:00 (CEST)

Keynote webinar | Spotlight on medication adherence

Live: Thursday 27th June 2024, 18:00-19:30 (CEST)

WHO estimates that half of all patients worldwide are non-adherent to their prescribed medication. The consequences of poor adherence can be catastrophic, on both the individual and population level.

Join our expert panel to discover why you need to understand the drivers of non-adherence in your patients, and how you can optimize medication adherence in your clinics to drastically improve patient outcomes.

Prof. Kevin Dolgin
Prof. Florian Limbourg
Prof. Anoop Chauhan
Developed by: Springer Medicine
Obesity Clinical Trial Summary

At a glance: The STEP trials

A round-up of the STEP phase 3 clinical trials evaluating semaglutide for weight loss in people with overweight or obesity.

Developed by: Springer Medicine